PhD researcher at the Department of PharmacoTherapy, University of Groningen. MSc at King’s College London and University College London in Pharmacology and Molecular Genetics. His research focuses on investigating pharmacogenetic variants in neurotransmitter pathways and conducting economic evaluations of genetic testing.